Nov
2026
IICC, Yashobhoomi, Dwarka, Delhi
Visit us
stand 2F26

BDR Pharmaceuticals International Pvt Ltd

Exhibitor at CPHI India 2026
About Us

BDR – A renowned name in the global pharmaceutical industry recognized for its Niche Molecules, Quality Products and for providing Affordable and Accessible Healthcare solutions.

BDR Group draws its expertise and reputation as a niche and innovative company by focusing its strategy on identifying prevailing therapeutic gaps, developing generic alternatives for various diseases currently affecting people. We also focus on addressing future diseases and ailments by adopting modern techn...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    India
  • On CPHI since:
    2015
  • Employees:
    1000 - 4999
Company types
Pharmaceutical company
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI India 2026
  • 23 Nov 2026 - 25 Nov 2026
  • IICC, Yashobhoomi, Dwarka, Delhi
  • Visit us at stand 2F26

Products Featured at CPHI India 2026

  • [(2,6- dimethylphenyl) aminocarbonylmethyl]-chloride [1311-01-7]

    Product [(2,6- dimethylphenyl) aminocarbonylmethyl]-chloride [1311-01-7]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes [(2,6- dimethylphenyl) aminocarbonylmethyl]-chloride [1311-01-7]. It belongs to ranolazine intermediates products category. Contact us for more information.
  • [1-hydroxy-2-(3-pyridinyl) ethylidene]-biphosphonic acid [105462-24-6]

    Product [1-hydroxy-2-(3-pyridinyl) ethylidene]-biphosphonic acid [105462-24-6]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes [1-hydroxy-2-(3-pyridinyl) ethylidene]-biphosphonic acid [105462-24-6]. It belongs to risedronate sodium intermediates products category. Contact us for more information.
  • [1,1'-biphenyl]-2-carbonitrile-4-[(2-butyl-4-oxo-1,3-diazaspiro [4.4]-non- 1-en-3-yl)- methyl]

    Product [1,1'-biphenyl]-2-carbonitrile-4-[(2-butyl-4-oxo-1,3-diazaspiro [4.4]-non- 1-en-3-yl)- methyl]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes [1,1'-biphenyl]-2-carbonitrile-4-[(2-butyl-4-oxo-1,3-diazaspiro [4.4]-non- 1-en-3-yl)- methyl]. It belongs to irbesartan intermediates products category. Contact us for more informat...
  • [138401-24-8]

    Product [138401-24-8]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes [138401-24-8]. It belongs to irbesartan intermediates products category. Contact us for more information.
  • 1- (2-methoxyphenoxy) -2,3-epoxypropane. [2210-74-4]

    Product 1- (2-methoxyphenoxy) -2,3-epoxypropane. [2210-74-4]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 1- (2-methoxyphenoxy) -2,3-epoxypropane. [2210-74-4]. It belongs to ranolazine intermediates products category. Contact us for more information.

BDR PHARMACEUTICALS INTERNATIONAL PVT. Resources (1)